Search

Thomas Sweeney Heard

Examiner (ID: 8001, Phone: (571)272-2064 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1654, 1675
Total Applications
1286
Issued Applications
710
Pending Applications
90
Abandoned Applications
491

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17451876 [patent_doc_number] => 11266713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-08 [patent_title] => Di-sulfide containing cell penetrating peptides and methods of making and using thereof [patent_app_type] => utility [patent_app_number] => 16/348706 [patent_app_country] => US [patent_app_date] => 2017-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 31582 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348706 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/348706
Di-sulfide containing cell penetrating peptides and methods of making and using thereof Nov 8, 2017 Issued
Array ( [id] => 17451876 [patent_doc_number] => 11266713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-08 [patent_title] => Di-sulfide containing cell penetrating peptides and methods of making and using thereof [patent_app_type] => utility [patent_app_number] => 16/348706 [patent_app_country] => US [patent_app_date] => 2017-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 31582 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348706 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/348706
Di-sulfide containing cell penetrating peptides and methods of making and using thereof Nov 8, 2017 Issued
Array ( [id] => 17451876 [patent_doc_number] => 11266713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-08 [patent_title] => Di-sulfide containing cell penetrating peptides and methods of making and using thereof [patent_app_type] => utility [patent_app_number] => 16/348706 [patent_app_country] => US [patent_app_date] => 2017-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 31582 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348706 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/348706
Di-sulfide containing cell penetrating peptides and methods of making and using thereof Nov 8, 2017 Issued
Array ( [id] => 15147773 [patent_doc_number] => 20190352364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => MANP Analogues [patent_app_type] => utility [patent_app_number] => 16/348652 [patent_app_country] => US [patent_app_date] => 2017-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348652 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/348652
MANP analogues Nov 8, 2017 Issued
Array ( [id] => 17451876 [patent_doc_number] => 11266713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-08 [patent_title] => Di-sulfide containing cell penetrating peptides and methods of making and using thereof [patent_app_type] => utility [patent_app_number] => 16/348706 [patent_app_country] => US [patent_app_date] => 2017-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 31582 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348706 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/348706
Di-sulfide containing cell penetrating peptides and methods of making and using thereof Nov 8, 2017 Issued
Array ( [id] => 14712791 [patent_doc_number] => 20190247459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => ANTIMICROBIAL COMPOSITION COMBINATIONS COMPRISING STAR SHAPED PEPTIDE POLYMERS [patent_app_type] => utility [patent_app_number] => 16/343556 [patent_app_country] => US [patent_app_date] => 2017-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23806 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343556 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/343556
Antimicrobial composition combinations comprising star shaped peptide polymers Nov 1, 2017 Issued
Array ( [id] => 14665041 [patent_doc_number] => 10370411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-06 [patent_title] => Beta-hairpin peptidomimetics [patent_app_type] => utility [patent_app_number] => 15/791087 [patent_app_country] => US [patent_app_date] => 2017-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18555 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15791087 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/791087
Beta-hairpin peptidomimetics Oct 22, 2017 Issued
Array ( [id] => 12177432 [patent_doc_number] => 20180036367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-08 [patent_title] => 'METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN' [patent_app_type] => utility [patent_app_number] => 15/789442 [patent_app_country] => US [patent_app_date] => 2017-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 43169 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15789442 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/789442
METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN Oct 19, 2017 Abandoned
Array ( [id] => 12606597 [patent_doc_number] => 20180094029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => METHODS OF TREATING OPHTHALMIC DISEASES USING NPR-B AGONISTS [patent_app_type] => utility [patent_app_number] => 15/786843 [patent_app_country] => US [patent_app_date] => 2017-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24807 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15786843 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/786843
METHODS OF TREATING OPHTHALMIC DISEASES USING NPR-B AGONISTS Oct 17, 2017 Abandoned
Array ( [id] => 15451389 [patent_doc_number] => 20200038518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => Mitochondrially Targeted PARP Inhibitor, and Uses Thereof [patent_app_type] => utility [patent_app_number] => 16/340237 [patent_app_country] => US [patent_app_date] => 2017-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13410 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340237 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/340237
Mitochondrially targeted PARP inhibitor, and uses thereof Oct 12, 2017 Issued
Array ( [id] => 15800111 [patent_doc_number] => 20200123198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => Peptide Libraries and Methods of Use [patent_app_type] => utility [patent_app_number] => 16/339189 [patent_app_country] => US [patent_app_date] => 2017-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24874 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339189 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/339189
Peptide Libraries and Methods of Use Oct 2, 2017 Abandoned
Array ( [id] => 16282668 [patent_doc_number] => 20200276270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => Combination Therapy with Controlled-Release CNP Agonists [patent_app_type] => utility [patent_app_number] => 16/338185 [patent_app_country] => US [patent_app_date] => 2017-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46707 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338185 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/338185
Combination therapy with controlled-release CNP agonists Sep 27, 2017 Issued
Array ( [id] => 17874363 [patent_doc_number] => 11446355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-20 [patent_title] => Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance [patent_app_type] => utility [patent_app_number] => 16/336334 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11491 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336334 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/336334
Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance Sep 25, 2017 Issued
Array ( [id] => 12584964 [patent_doc_number] => 20180086817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => Preventing, Treating or Arresting Alzheimer's, Stroke, Cardiovascular and other Amyloid Related Diseases [patent_app_type] => utility [patent_app_number] => 15/712985 [patent_app_country] => US [patent_app_date] => 2017-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6815 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -73 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15712985 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/712985
Preventing, Treating or Arresting Alzheimer's, Stroke, Cardiovascular and other Amyloid Related Diseases Sep 21, 2017 Abandoned
Array ( [id] => 12637332 [patent_doc_number] => 20180104274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => POLYPEPTIDE HAVING THE CAPACITY TO FORM ALPHA-1,3 GLUCOSYL UNIT BRANCHINGS ON AN ACCEPTOR [patent_app_type] => utility [patent_app_number] => 15/712173 [patent_app_country] => US [patent_app_date] => 2017-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8881 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15712173 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/712173
Polypeptide having the capacity to form alpha-1,3 glucosyl unit branchings on an acceptor Sep 21, 2017 Issued
Array ( [id] => 16876813 [patent_doc_number] => 11026933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-08 [patent_title] => Compositions and methods for treatment of cancer [patent_app_type] => utility [patent_app_number] => 16/332404 [patent_app_country] => US [patent_app_date] => 2017-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 11338 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332404 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/332404
Compositions and methods for treatment of cancer Sep 19, 2017 Issued
Array ( [id] => 14581281 [patent_doc_number] => 20190218249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => A PROCESS FOR PURIFICATION OF CARFILZOMIB INTERMEDIATE [patent_app_type] => utility [patent_app_number] => 16/332717 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3980 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332717 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/332717
Process for purification of carfilzomib intermediate Sep 12, 2017 Issued
Array ( [id] => 14406795 [patent_doc_number] => 20190169241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => KIF13B-DERIVED PEPTIDE AND METHOD OF INHIBITING ANGIOGENESIS [patent_app_type] => utility [patent_app_number] => 16/325006 [patent_app_country] => US [patent_app_date] => 2017-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13961 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325006 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/325006
KIF13B-derived peptide and method of inhibiting angiogenesis Aug 30, 2017 Issued
Array ( [id] => 13702695 [patent_doc_number] => 20170362302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => Method and Pharmaceutical Composition for Use in the Treatment of Cancer [patent_app_type] => utility [patent_app_number] => 15/687692 [patent_app_country] => US [patent_app_date] => 2017-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13538 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687692 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/687692
Method and Pharmaceutical Composition for Use in the Treatment of Cancer Aug 27, 2017 Abandoned
Array ( [id] => 16246110 [patent_doc_number] => 10745451 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Scorpion toxin fusion protein with enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle, enhancing skin elasticity and anti-aging comprising the same as an effective ingredient [patent_app_type] => utility [patent_app_number] => 16/328107 [patent_app_country] => US [patent_app_date] => 2017-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 6481 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328107 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/328107
Scorpion toxin fusion protein with enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle, enhancing skin elasticity and anti-aging comprising the same as an effective ingredient Aug 24, 2017 Issued
Menu